Related articles

Experts share their insights on different health topics and how comprehensive healthcare solutions can treat different conditions to improve patient health.

New direction after drug resistance: CTC in vitro drug sensitivity detection helps personalized drug selection

With advancements in cancer-related care, many patients achieve favorable outcomes during initial treatments. However, over time, some patients may develop drug resistance, which presents challenges for maintaining efficacy. Drug resistance is not limited to traditional chemical drugs but can also occur in targeted therapies and immunotherapy. Selecting the appropriate treatment to address resistance has become a significant challenge in cancer care. Circulating Tumor Cell (CTC)-based drug sensitivity testing, as a new approach for personalized drug selection, provides a promising direction for overcoming drug resistance.

Read More »

Heavy Metal Burden and Liver Cancer Risk: From Detection and Assessment to Comprehensive Management

Heavy metal contamination has gradually become an undeniable health concern in modern society. Prolonged accumulation of heavy metals may have negative effects on multiple organ systems, especially the liver. As a vital detoxification organ in the body, the liver can be compromised when exposed to heavy metals over time, potentially increasing the risk of certain liver diseases, including liver cancer. This article explores the potential connection between heavy metal burden and liver cancer, and proposes strategies to reduce risk through scientific detection and comprehensive management.

Read More »

High-dose vitamin C: exploring its potential to enhance the synergy between radiotherapy and chemotherapy care

In recent years, high-dose vitamin C (VC) has received some attention in the field of cancer auxiliary care. In addition to its traditional antioxidant effects, some preliminary studies suggest that high doses of vitamin C may be associated with certain biological response markers when used in conjunction with radiological or chemical procedures. This article aims to discuss some of the preliminary observed mechanisms of action and safety considerations for use, and emphasizes that the content of this article is for reference only and should not be regarded as any form of medical advice.

Read More »

Care and protection combination: Vitamin C + selenium + glutathione

Chemotherapy is a critical component of cancer treatment for many patients, but it often brings about numerous side effects, including immune system suppression, nausea, fatigue, and cellular damage. To help alleviate these side effects and improve the quality of life for chemotherapy patients, several studies have shown the beneficial role of certain antioxidants and nutrients. Among these, the combination of Vitamin C, Selenium, and Glutathione has been recognized for its protective effects in chemotherapy patients. Below are the roles of these three components and how they work together to provide necessary protective support.

Read More »

Early Detection of Lung Cancer Through RGCC Technology

Lung cancer remains one of the most common cancers worldwide, with a high mortality rate. One of the primary challenges in lung cancer management is its late diagnosis, as early-stage lung cancer often presents with no obvious symptoms. As a result, many patients are diagnosed at an advanced stage, limiting their treatment options and reducing survival rates. While conventional screening methods such as chest X-rays and CT scans can detect certain abnormalities, they often lack the sensitivity to identify lung cancer in its earliest stages. This makes the search for more precise early detection methods essential for improving patient outcomes.

Read More »

Personalized Cancer Care Plan: How RGCC Designs It Based on Your Genetic Characteristics

With the rapid development of precision medicine and genomics, cancer treatment is moving toward a more personalized approach. Personalized cancer care plans are tailored to each patient based on their genetic background, cancer type, immune status, and other physiological factors. RGCC (Research Genetic Cancer Centre) uses advanced genetic testing technologies to help cancer patients create more accurate care plans based on their individual genetic characteristics, enhancing treatment outcomes and minimizing side effects.

Read More »

The Hidden Threat After Surgery: RGCC Detection of Circulating Tumor Cell Micro Residue

Surgery is often the first step in the treatment of cancer patients. However, even when the surgery successfully removes the tumor, the risk of cancer recurrence still exists. Traditional imaging and histological tests can only detect significant changes when the tumor has grown or metastasized, making it impossible to capture the tiny remnants of cancer cells in time. This means that many patients may appear to be cancer-free after surgery, but potential cancer cells remain, leading to disease recurrence.

Read More »

EDTA Precision Detox: Personalized Dosage Titration Scheme Based on Renal Toxicology Testing

With the increasing threat of heavy metal accumulation due to environmental pollution and lifestyle changes, more individuals are facing the risk of heavy metal toxicity. EDTA (Ethylenediaminetetraacetic acid) chelation therapy has been widely applied as an effective method to eliminate accumulated heavy metals from the body. As a commonly used chelating agent, EDTA has been proven to have significant detoxifying effects for heavy metal poisoning. However, its use requires precise dosage titration based on an individual’s health condition, especially renal function testing, which significantly enhances efficacy and reduces potential side effects.

Read More »

Dual Application of Liquid Biopsy: RGCC CTC Testing for Simultaneous Evaluation of Tumor Metastasis and Nutritional Status

With advancements in tumor detection technology, liquid biopsy has emerged as a non-invasive method with immense potential in early tumor screening, metastasis monitoring, and treatment evaluation. Particularly, RGCC CTC (Circulating Tumor Cell) testing is gaining increasing importance in tumor care. This technology provides crucial information on tumor metastasis while simultaneously assessing the patient’s nutritional status, offering valuable insights for developing personalized care plans.

Read More »